Unilever emerges as leading bidder for GSK’s Indian Horlicks ops


Traffic and people pass by the front of the Unilever building in central London, Britain. - Reuters filepic

HONG KONG: Unilever PLC has emerged as the leading bidder in a tight contest for GlaxoSmithKline PLC’s Indian Horlicks nutrition business, sources told Reuters.

If it is able to clinch the deal, Unilever will trump fellow European consumer giant Nestle SA, which according to an Indian media report earlier yesterday was close to buying Horlicks and other GSK consumer healthcare assets in India.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Horlicks , Unilever , Nestle ,

   

Next In Business News

Trade showing remains on upward trajectory
Maxis pledges full support to government’s 5G delivery model
Fajarbaru Builder secures RM13mil job
MKH Oil Palm IPO oversubscribed
The pros and cons of earned wage access
Making every load lighter
Making the Malaysian startup pitch
How Sin-Kung leveraged air cargo for its success
Domestic office-sector REITs stay cautious
‘Muted optimism’

Others Also Read